Effect of second tumors and of prostaglandin-leukotriene inhibitors on radiation therapy of transplanted rodent tumors

The prostaglandin and leukotriene inhibitor sodium meclofenamate (SM) failed to influence radiation therapy induced regression of 6C3HED Gardner lymphosarcoma in C3H mice. Recurrence after radiation therapy, however, was reduced by treatment with SM. During these experiments, we observed that if a t...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of medicine Vol. 15; no. 2; p. 93
Main Authors:	Ambrus, J L, Ambrus, C M, Halpern, J, Gastpar, H
Format:	Journal Article
Language:	English
Published:	United States 1984
Subjects:	Animals Autacoids - antagonists & inhibitors Autacoids - physiology Dinoprostone Lymphoma, Non-Hodgkin - immunology Lymphoma, Non-Hodgkin - pathology Lymphoma, Non-Hodgkin - radiotherapy Meclofenamic Acid - pharmacology Mice Mice, Inbred C3H Neoplasm Transplantation ortho-Aminobenzoates - pharmacology Prostaglandin Antagonists - pharmacology Prostaglandins E - physiology Transplantation Immunology - drug effects
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The prostaglandin and leukotriene inhibitor sodium meclofenamate (SM) failed to influence radiation therapy induced regression of 6C3HED Gardner lymphosarcoma in C3H mice. Recurrence after radiation therapy, however, was reduced by treatment with SM. During these experiments, we observed that if a tumor was "cured" by radiation therapy, it required inoculation of a larger number of cells to establish a second tumor. Presumably, a certain degree of immunity has developed. On the other hand, if a second tumor was already established, less tumor cells were needed to establish a third tumor. This may be related to immuno-suppressor products of the second tumor. This effect could be partly inhibited by SM, suggesting that prostaglandins and leukotrienes may be involved in this phenomenon.
ISSN:	0025-7850